HIPRA Biotech Services

Amer, ES
Biologics mRNA
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (1) ○ EMA GMP ○ MHRA GMP

Quick Facts: HIPRA Biotech Services

Signal Score
63.0/100 (as of 2026-04-29)
Quality Compliance
Assessment pending
Headquarters
Amer, ES
Modalities
Biologics, mRNA
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About HIPRA Biotech Services

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesBiologics, mRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: HIPRA
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: HIPRA
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Amer, ES
Modalities: Biologics, mRNA
Capacity assessment: 58.0/100
Sites: Amer, ES
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press1 articles
1 manufacturing site: Amer, ES
Modalities: Biologics, mRNA
Capacity assessment: 58.0/100

Recent News 1 articles

capacity 2026-03-19
HIPRA Biotech Expands Biologics Capacity - Contract Pharma
HIPRA Biotech Expands Biologics Capacity  Contract Pharma
Source →

Frequently Asked Questions About HIPRA Biotech Services

What is HIPRA Biotech Services's CDMO Signal Score?
HIPRA Biotech Services has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating HIPRA Biotech Services for a manufacturing program?
Use the free AI matchmaker to compare HIPRA Biotech Services against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics CDMOs → mRNA CDMOs →

Similar CDMOs

Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Evonik Health Care
Birmingham, AL · Vancouver, BC
Signal Score: 81.5
mRNA, Biologics
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.4
mRNA, Oligonucleotide, Biologics